News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
219,882 Results
Type
Article (4746)
Company Profile (70)
Press Release (215059)
Section
Business (72166)
Career Advice (97)
Deals (11889)
Drug Delivery (3)
Drug Development (34369)
Employer Resources (12)
FDA (3856)
Job Trends (3775)
News (112511)
Policy (8339)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (244)
Accelerated approval (18)
ADA (7)
Allergies (78)
Alliances (16716)
ALS (90)
Alzheimer's disease (575)
Antibody-drug conjugate (ADC) (281)
Approvals (4320)
Artificial intelligence (177)
ASCO (105)
Autoimmune disease (180)
Automation (10)
Bankruptcy (57)
Belgium (2)
Best Places to Work (3225)
BIO (26)
Biologics (7)
BIOSECURE Act (2)
Biosimilars (159)
BioSpace Insights (2)
Biotechnology (49)
Bladder cancer (82)
Brain cancer (27)
Breast cancer (234)
Cancer (2307)
Cardiovascular disease (135)
Career advice (91)
Career pathing (3)
CAR-T (115)
CDC (3)
CDMO (28)
Celiac Disease (2)
Cell therapy (265)
Cervical cancer (16)
Clinical research (32447)
Collaboration (884)
Commercialization (4)
Compensation (946)
Complete response letters (25)
COVID-19 (563)
CRISPR (31)
C-suite (589)
Cystic fibrosis (45)
Data (3822)
Depression (82)
Dermatology (48)
Diabetes (177)
Diagnostics (1003)
Digital health (8)
Diversity, equity & inclusion (2)
Drug discovery (110)
Drug pricing (12)
Drug shortages (1)
Duchenne muscular dystrophy (106)
Earnings (29073)
Editorial (3)
Employer branding (1)
Employer resources (11)
Events (40117)
Executive appointments (480)
FDA (5540)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (540)
Gene editing (58)
Generative AI (12)
Gene therapy (143)
GLP-1 (278)
Government (616)
Grass and pollen (1)
Guidances (150)
Healthcare (2757)
Hematology (78)
HIV (39)
Huntington's disease (10)
IgA nephropathy (52)
Immunology and inflammation (71)
Immuno-oncology (39)
Indications (108)
Infectious disease (655)
Inflammatory bowel disease (92)
Inflation Reduction Act (1)
Influenza (34)
Intellectual property (130)
Interviews (13)
IPO (6366)
IRA (3)
Job creations (706)
Job search strategy (82)
JPM (5)
Kidney cancer (18)
Kidney disease (34)
Labor market (2)
Layoffs (37)
Leadership (2)
Legal (1515)
Licensing (18)
Liver cancer (41)
Longevity (10)
Lung cancer (410)
Lymphoma (220)
Machine learning (16)
Management (4)
Manufacturing (433)
Marketing (9)
MASH (135)
Medical affairs (1)
Medical device (1424)
Medtech (1449)
Mergers & acquisitions (6167)
Metabolic disorders (528)
mRNA (26)
Multiple sclerosis (86)
NASH (7)
Netherlands (2)
Neurodegenerative disease (135)
Neuropsychiatric disorders (39)
Neuroscience (1243)
NextGen: Class of 2026 (883)
Non-profit (246)
Now hiring (5)
Obesity (193)
Opinion (24)
Ovarian cancer (69)
Pain (82)
Pancreatic cancer (99)
Parkinson's disease (140)
Partnered (4)
Patents (241)
Patient recruitment (379)
Patient selection (4)
Peanut (24)
People (19508)
Peptides (2)
Pharmaceutical (22)
Pharmacy benefit managers (5)
Phase 1 (9459)
Phase 2 (14544)
Phase 3 (10948)
Pipeline (4893)
Policy (18)
Postmarket research (669)
Preclinical (3469)
Press Release (13)
Prostate cancer (106)
Psychedelics (5)
Radiopharmaceuticals (145)
Rare diseases (399)
Real estate (1401)
Recruiting (7)
Regenerative medicine (1)
Regulatory (8399)
Reports (16)
Research institute (282)
Resumes & cover letters (6)
Rett syndrome (1)
RNA editing (6)
RSV (18)
Schizophrenia (130)
Series A (96)
Series B (75)
Service/supplier (2)
Sickle cell disease (38)
Spinal muscular atrophy (54)
Sponsored (5)
Startups (1017)
State (1)
Stomach cancer (2)
Substance use disorders (9)
Supply chain (29)
Tariffs (7)
Vaccines (208)
Venture capital (14)
Weight loss (56)
Women's health (19)
Worklife (1)
Date
Today (49)
Last 7 days (173)
Last 30 days (914)
Last 365 days (11267)
2026 (8167)
2025 (11127)
2024 (12882)
2023 (14847)
2022 (19450)
2021 (20681)
2020 (18060)
2019 (11597)
2018 (8428)
2017 (10485)
2016 (8874)
2015 (11434)
2014 (8684)
2013 (6593)
2012 (6656)
2011 (6733)
2010 (6576)
Location
Africa (148)
Alabama (22)
Arizona (60)
Arkansas (3)
Asia (28786)
Australia (3604)
California (5723)
Canada (1285)
China (1254)
Colorado (166)
Connecticut (269)
Delaware (265)
Europe (33400)
Florida (820)
Georgia (169)
Hawaii (1)
Idaho (3)
Illinois (291)
India (69)
Indiana (185)
Iowa (12)
Japan (470)
Kansas (82)
Kentucky (11)
Louisiana (4)
Maine (6)
Maryland (556)
Massachusetts (4568)
Michigan (55)
Minnesota (213)
Mississippi (1)
Missouri (26)
Montana (1)
Nebraska (7)
Nevada (35)
New Hampshire (6)
New Jersey (1991)
New Mexico (4)
New York (1726)
North Carolina (704)
Northern California (3123)
Ohio (134)
Oklahoma (8)
Oregon (11)
Pennsylvania (990)
Puerto Rico (5)
Rhode Island (4)
South America (201)
South Carolina (6)
Southern California (2263)
Tennessee (28)
Texas (617)
United States (19895)
Utah (119)
Vermont (1)
Virginia (185)
Washington D.C. (16)
Washington State (357)
Wisconsin (27)
Wyoming (1)
219,882 Results for "xtl biopharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XTL Biopharmaceuticals Announces ADS Ratio Change
March 23, 2026
·
4 min read
Press Releases
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026
·
5 min read
Press Releases
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
January 14, 2026
·
8 min read
Press Releases
XTL Update on Recent Developments
January 30, 2026
·
3 min read
Press Releases
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
March 2, 2026
·
4 min read
Press Releases
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
January 26, 2026
·
4 min read
Press Releases
SK Biopharmaceuticals to In-License Epilepsy Drug Candidate ‘Opakalim’
August 26, 2026
·
15 min read
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
XTL Biopharmaceuticals Ltd. announced that the Company received a written notification from the Nasdaq Stock Market LLC on October 18, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Rules for continued listing on the Nasdaq.
October 20, 2023
·
5 min read
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Press Releases
XTL Names Mr. Noam Band as its New Chief Executive Officer
April 8, 2025
·
3 min read
1 of 21,989
Next
